For partnering collaborations involving pre-clinical programs and platform technologies for drug discovery please contact: Arthur Bertelsen, Ph.D. Executive Director Discovery Collaboration & Technology Licensing Schering-Plough Research Institute DCTL.inquiries@spcorp.com
For partnering collaborations related to human therapeutics in clinical development, please contact: Roz Feder, M.D., Ph.D. Vice President, Business Development & Licensing Schering-Plough Corporation BD.inquiries@spcorp.com
Human Prescription Products in Development Directions to our Kenilworth, New Jersey location click here.
Click here for more information on REMICADE
CEO Fred Hassan's Remarks from the 3rd Annual Cardiovascular Summit: "Improving Cardiovascular Care: A Noble Mission." Read More >